Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
Koumi Miyasaka, Sakiko Hirofuji, Mika Maezawa, Satoshi Nakao, Moe Yamashita, Nanaka Ichihara, Yuka Nokura, Hirofumi Tamaki, Kazuhiro Iguchi, Mitsuhiro Nakamur. Evaluation of Antipsychotic-Induced Neuroleptic Malignant Syndrome Using a Self-Organizing Map. Cureus. vol 16. issue 8. 2024-10-01. PMID:39350836. |
the numbers of cases of nms (smq code: 20000044) reported for risperidone, aripiprazole, haloperidol, olanzapine, and quetiapine were 1691, 1294, 1132, 1056, and 986, respectively. |
2024-10-01 |
2024-10-03 |
Not clear |
Sakiko Hirofuji, Koumi Miyasaka, Mika Maezawa, Wataru Wakabayashi, Keita Oura, Satoshi Nakao, Nanaka Ichihara, Yuka Nokura, Moe Yamashita, Kensuke Matsui, Hideyuki Tanaka, Mayuko Masuta, Ichiro Ieiri, Kazuhiro Iguchi, Mitsuhiro Nakamur. Evaluation of neuroleptic malignant syndrome induced by antipsychotic drugs using spontaneous reporting system. Heliyon. vol 9. issue 11. 2023-11-30. PMID:38034668. |
rors (95 % confidence interval) of nms for haloperidol, chlorpromazine, risperidone, and aripiprazole were 12.1 (11.1-13.3), 6.3 (5.7-7.0), 6.2 (5.8-6.6), and 4.7 (4.4-5.1), respectively. |
2023-11-30 |
2023-12-10 |
Not clear |
Autumn R Schultz, Sarina Singh, Carolyn E Linek-Rajapaksha, Heather R Goode, Adam J Fusic. A Case of Neuroleptic Malignant Syndrome in the Context of Lithium Toxicity and Aripiprazole Use. Clinical neuropharmacology. 2023-10-24. PMID:37874611. |
considerable evidence, however, has suggested that atypical antipsychotics are associated with nms, including the partial dopamine agonist, aripiprazole. |
2023-10-24 |
2023-11-08 |
Not clear |
Autumn R Schultz, Sarina Singh, Carolyn E Linek-Rajapaksha, Heather R Goode, Adam J Fusic. A Case of Neuroleptic Malignant Syndrome in the Context of Lithium Toxicity and Aripiprazole Use. Clinical neuropharmacology. 2023-10-24. PMID:37874611. |
here, the authors present a case of a patient who developed nms from lithium and aripiprazole and provide a literature review of reported nms cases with either psychotropic. |
2023-10-24 |
2023-11-08 |
Not clear |
Fuminari Misawa, Yasuyuki Okumura, Yoshinori Takeuchi, Yasuo Fujii, Hiroyoshi Takeuch. Neuroleptic malignant syndrome associated with long-acting injectable versus oral second-generation antipsychotics: Analyses based on a spontaneous reporting system database in Japan. Schizophrenia research. vol 231. 2021-07-05. PMID:33752105. |
lai aripiprazole and lai paliperidone were associated with a significantly lower reporting frequency of nms than the equivalent oral sgas (adjusted reporting odds ratio [95% confidence interval]: 0.35 [0.19-0.63] and 0.40 [0.27-0.59], respectively). |
2021-07-05 |
2023-08-13 |
Not clear |
Fuminari Misawa, Yasuyuki Okumura, Yoshinori Takeuchi, Yasuo Fujii, Hiroyoshi Takeuch. Neuroleptic malignant syndrome associated with long-acting injectable versus oral second-generation antipsychotics: Analyses based on a spontaneous reporting system database in Japan. Schizophrenia research. vol 231. 2021-07-05. PMID:33752105. |
the proportion of mortality due to nms associated with oral aripiprazole was 13.1% and no deaths occurred in patients with nms associated with lai aripiprazole. |
2021-07-05 |
2023-08-13 |
Not clear |
Oona Nørgaard van Achter, Selvavathany Sivagurunatha. [Neuroleptic malignant syndrome treated with electroconvulsive therapy]. Ugeskrift for laeger. vol 182. issue 48. 2021-06-11. PMID:33269687. |
this is a case report of nms induced by second-generation antipsychotic treatment with aripiprazole causing symptoms of rigidity, altered mental status, diaphoresis and creatine kinase elevation. |
2021-06-11 |
2023-08-13 |
Not clear |
Anna Maria Szota, Izabela Radajewska, Przemysław Grudzka, Aleksander Araszkiewic. Lamotrigine, quetiapine and aripiprazole-induced neuroleptic malignant syndrome in a patient with renal failure caused by lithium: a case report. BMC psychiatry. vol 20. issue 1. 2020-12-21. PMID:32306929. |
neuroleptic malignant syndrome (nms) may be induced by atypical antipsychotic drugs (aapds) such as aripiprazole, olanzapine, risperidone and quetiapine, either as a single treatment or in combination with other drugs. |
2020-12-21 |
2023-08-13 |
Not clear |
Anna Maria Szota, Izabela Radajewska, Przemysław Grudzka, Aleksander Araszkiewic. Lamotrigine, quetiapine and aripiprazole-induced neuroleptic malignant syndrome in a patient with renal failure caused by lithium: a case report. BMC psychiatry. vol 20. issue 1. 2020-12-21. PMID:32306929. |
a case of nms following the administration of lamotrigine, aripiprazole and quetiapine in a patient with bipolar disorder, and with renal failure caused by toxic lithium levels has not been reported. |
2020-12-21 |
2023-08-13 |
Not clear |
Naoto Mizumura, Masato Uematsu, Aya Ito, Satoshi Okumura, Hiromitsu Maehira, Masao Ogawa, Masayasu Kawasak. "Brief" Aripiprazole-induced Neuroleptic Malignant Syndrome with Symptoms that Only Lasted a Few Hours. Internal medicine (Tokyo, Japan). vol 56. issue 22. 2018-05-14. PMID:28943586. |
atypical nms usually lacks major symptoms and frequently occurs after treatment using atypical antipsychotics, such as aripiprazole. |
2018-05-14 |
2023-08-13 |
Not clear |
Rita Sridaran, Chadd E Nesbi. Acute Dystonia Versus Neuroleptic Malignant Syndrome Without Fever in an Eight-Year-Old Child. Pediatric emergency care. vol 33. issue 1. 2017-04-24. PMID:28045840. |
we compare this case with the other documented cases of acute dystonia and nms after initiating aripiprazole in the pediatric population. |
2017-04-24 |
2023-08-13 |
Not clear |
Rita Sridaran, Chadd E Nesbi. Acute Dystonia Versus Neuroleptic Malignant Syndrome Without Fever in an Eight-Year-Old Child. Pediatric emergency care. vol 33. issue 1. 2017-04-24. PMID:28045840. |
we describe a case of a pediatric patient who developed an acute dystonic reaction versus nms soon after starting aripiprazole. |
2017-04-24 |
2023-08-13 |
Not clear |
Ping-Tao Tseng, Yi-Chung Chang, Chih-Hua Chang, Hung-Yu Wang, Yu-Shian Cheng, Ching-Kuan Wu, Yen-Wen Chen, Weilun Chun. Atypical neuroleptic malignant syndrome in patients treated with aripiprazole and clozapine: a case-series study and short review. International journal of psychiatry in medicine. vol 49. issue 1. 2015-09-15. PMID:25838319. |
herein, we present two cases of atypical nms treated with aripiprazole and clozapine. |
2015-09-15 |
2023-08-13 |
Not clear |
Ping-Tao Tseng, Yi-Chung Chang, Chih-Hua Chang, Hung-Yu Wang, Yu-Shian Cheng, Ching-Kuan Wu, Yen-Wen Chen, Weilun Chun. Atypical neuroleptic malignant syndrome in patients treated with aripiprazole and clozapine: a case-series study and short review. International journal of psychiatry in medicine. vol 49. issue 1. 2015-09-15. PMID:25838319. |
combined aripiprazole and clozapine therapy is rarely used in clinical settings, and nms related this combination still lacks evaluation. |
2015-09-15 |
2023-08-13 |
Not clear |
Praveen Tripathi, Hemika Agrawal, Priyanka Goyal, Sujita Kumar Ka. Olanzapine-induced neuroleptic malignant syndrome in a patient with bipolar affective disorder: Does quetiapine holds the solution? Industrial psychiatry journal. vol 22. issue 2. 2014-07-11. PMID:25013321. |
it is commonly encountered with the use of first generation antipsychotics, however cases of nms have been reported with the use of second generation antipsychotics like olanzapine, risperidone, paliperidone, aripiprazole, ziprasidone, amisulpride, quetiapine and clozapine, though the incidence of such reports is rare. |
2014-07-11 |
2023-08-13 |
Not clear |
Zexiang Ouyang, Li Ch. A case of recurrent neuroleptic malignant syndrome. Shanghai archives of psychiatry. vol 25. issue 4. 2014-07-03. PMID:24991164. |
nms occurred after combined treatment with haloperidol and aripiprazole (the first episode) and, four years later, after combined treatment with haloperidol and clozapine (the second episode). |
2014-07-03 |
2023-08-13 |
Not clear |
Mitesh K Patel, Luigi Brunett. Neuroleptic malignant syndrome secondary to aripiprazole initiation in a clozapine-intolerant patient. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. vol 67. issue 15. 2010-11-16. PMID:20651315. |
a case of neuroleptic malignant syndrome (nms) secondary to aripiprazole in a schizophrenic patient previously managed with clozapine is reported. |
2010-11-16 |
2023-08-12 |
Not clear |
Julian N Trollor, Xiaohua Chen, Perminder S Sachde. Neuroleptic malignant syndrome associated with atypical antipsychotic drugs. CNS drugs. vol 23. issue 6. 2009-08-18. PMID:19480467. |
we used medline and embase to identify nms case reports and systematic reviews published to june 2008 related to the atypical antipsychotic drugs clozapine, olanzapine, risperidone, paliperidone, aripiprazole, ziprasidone, amisulpride and quetiapine. |
2009-08-18 |
2023-08-12 |
Not clear |
Paul E Croarkin, Graham J Emslie, Taryn L Maye. Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases. The Journal of clinical psychiatry. vol 69. issue 7. 2008-09-09. PMID:18572981. |
to retrospectively examine published cases of neuroleptic malignant syndrome (nms) in patients aged 18 and below who had been treated with atypical antipsychotics (clozapine, risperidone, olanzapine, quetiapine, ziprasidone, and aripiprazole). |
2008-09-09 |
2023-08-12 |
Not clear |
Orson P Rodriguez, Matthew S Dowel. A case report of neuroleptic malignant syndrome without fever in a patient given aripiprazole. The Journal of the Oklahoma State Medical Association. vol 99. issue 7. 2006-11-03. PMID:17017330. |
the authors present an unusual case of nms in a schizophrenic patient without fever who had been on aripiprazole. |
2006-11-03 |
2023-08-12 |
Not clear |